233 related articles for article (PubMed ID: 21372041)
1. CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells.
Kim EH; Deng CX; Sporn MB; Liby KT
Cancer Prev Res (Phila); 2011 Mar; 4(3):425-34. PubMed ID: 21372041
[TBL] [Abstract][Full Text] [Related]
2. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
Place AE; Suh N; Williams CR; Risingsong R; Honda T; Honda Y; Gribble GW; Leesnitzer LM; Stimmel JB; Willson TM; Rosen E; Sporn MB
Clin Cancer Res; 2003 Jul; 9(7):2798-806. PubMed ID: 12855660
[TBL] [Abstract][Full Text] [Related]
3. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
So JY; Lin JJ; Wahler J; Liby KT; Sporn MB; Suh N
PLoS One; 2014; 9(9):e107616. PubMed ID: 25229616
[TBL] [Abstract][Full Text] [Related]
4. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
Cao M; Onyango EO; Williams CR; Royce DB; Gribble GW; Sporn MB; Liby KT
Pharmacol Res; 2015 Oct; 100():135-47. PubMed ID: 26238177
[TBL] [Abstract][Full Text] [Related]
5. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
[TBL] [Abstract][Full Text] [Related]
6. 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer.
Samudio I; Konopleva M; Hail N; Shi YX; McQueen T; Hsu T; Evans R; Honda T; Gribble GW; Sporn M; Gilbert HF; Safe S; Andreeff M
J Biol Chem; 2005 Oct; 280(43):36273-82. PubMed ID: 16118208
[TBL] [Abstract][Full Text] [Related]
7. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid.
Ikeda T; Nakata Y; Kimura F; Sato K; Anderson K; Motoyoshi K; Sporn M; Kufe D
Mol Cancer Ther; 2004 Jan; 3(1):39-45. PubMed ID: 14749474
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and apoptosis of human multiple myeloma cells induced by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid derivatives.
Rogers LJ; John T; Park J; Tucker M; Ma H; Wu Y; Rayalam S; Wang X
Anticancer Drugs; 2020 Sep; 31(8):806-818. PubMed ID: 32304407
[TBL] [Abstract][Full Text] [Related]
9. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
[TBL] [Abstract][Full Text] [Related]
10. CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.
Kim EH; Deng C; Sporn MB; Royce DB; Risingsong R; Williams CR; Liby KT
Cancer Prev Res (Phila); 2012 Jan; 5(1):89-97. PubMed ID: 21933912
[TBL] [Abstract][Full Text] [Related]
11. The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta.
Yore MM; Liby KT; Honda T; Gribble GW; Sporn MB
Mol Cancer Ther; 2006 Dec; 5(12):3232-9. PubMed ID: 17148759
[TBL] [Abstract][Full Text] [Related]
12. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
[TBL] [Abstract][Full Text] [Related]
13. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
[TBL] [Abstract][Full Text] [Related]
14. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
[TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
16. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
[TBL] [Abstract][Full Text] [Related]
17. Targeting glutathione with the triterpenoid CDDO-Im protects against benzo-a-pyrene-1,6-quinone-induced cytotoxicity in endothelial cells.
Shukla H; Lee HY; Koucheki A; Bibi HA; Gaje G; Sun X; Zhu H; Li YR; Jia Z
Mol Cell Biochem; 2020 Nov; 474(1-2):27-39. PubMed ID: 32715408
[TBL] [Abstract][Full Text] [Related]
18. The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
Chauhan D; Li G; Podar K; Hideshima T; Shringarpure R; Catley L; Mitsiades C; Munshi N; Tai YT; Suh N; Gribble GW; Honda T; Schlossman R; Richardson P; Sporn MB; Anderson KC
Blood; 2004 Apr; 103(8):3158-66. PubMed ID: 15070698
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotection of human endothelial cells against oxidative stress by 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im): application of systems biology to understand the mechanism of action.
Wang X; Bynum JA; Stavchansky S; Bowman PD
Eur J Pharmacol; 2014 Jul; 734():122-31. PubMed ID: 24703885
[TBL] [Abstract][Full Text] [Related]
20. Protection of HepG2 cells against acrolein toxicity by 2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide via glutathione-mediated mechanism.
Shah H; Speen AM; Saunders C; Brooke EA; Nallasamy P; Zhu H; Li YR; Jia Z
Exp Biol Med (Maywood); 2015 Oct; 240(10):1340-51. PubMed ID: 25504014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
